Sanofi

Showing 15 posts of 579 posts found.

ipsen_small

Ipsen to acquire Sanofi assets in $88 million deal

February 13, 2017
Sales and Marketing Boehringer Ingelheim, Prontalgine, Sanofi, ipsen

Ipsen has announced that it is set to enter into a definitive agreement to acquire five consumer healthcare products from …

Sanofi & Regeneron deflect Amgen’s legal marketing block on Praluent

February 9, 2017
Manufacturing and Production, Sales and Marketing Amgen, Regeneron, Repatha, Sanofi, praluent

Sanofi and Regeneron have successfully won in a US Court ruling calling for the suspension of the permanent injunction of …

hugo_fry

Sanofi reinforces senior staff with two new execs

February 6, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi

Sanofi has reinforced its senior staff with a double-whammy of appointments; firstly, the French firm has announced that it is …

Sanofi & Regeneron’s arthritis drug scores first approval following FDA rejection

February 1, 2017
Research and Development, Sales and Marketing Actemra, Humira, Kevzara, Regeneron, Roche, Sanofi, sarilumab

Kevzara (sarilumab), a interleukin-6 (IL06) receptor antibody developed by Sanofi and Regeneron and the first real competitor to Roche’s Actemra …

insulin-syringe-1972843_960_720

Price-fixing class action lawsuit levelled at three major insulin producers

January 31, 2017
Manufacturing and Production, Sales and Marketing Eli Lilly, Novo Nordisk, Sanofi, diabetes, insulin, price-fixing

A group of patients has filed a class action lawsuit in a federal court in Massachusetts, accusing three companies of …

kathleen_tregoning

Sanofi announces new VP of External Affairs

January 30, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi

Kathleen Tregoning has been announced as Sanofi’s vice president of External Affairs and as a new member of the Executive …

Sanofi diabetes drug Sulinqua green-lighted in Europe

January 19, 2017
Research and Development, Sales and Marketing Sanofi, Sulinqua

Sanofi’s diabetes drug Suliqua has been granted marketing authorisation by the European Commission, giving the go ahead for the launch …

access_accelerated

22 pharma companies join forces for global non-communicable disease initiative

January 18, 2017
Research and Development BMS, Celgene, Eisai, Eli Lilly, GSK, J&J, JJ, MSD, Merck, Novartis, Pfizer, Roche, Sanofi, Takeda

The World Economic Forum Annual Meeting in Switzerland has seen the launch of Access Accelerated, a global initiative consisting of …

dengue_mosquito_web

Philippine FDA orders Sanofi to pull dengue vaccine ads

January 5, 2017
Medical Communications, Sales and Marketing Philippines, Sanofi, Vaccine, dengue, virus

Sanofi has suffered a major blow to its dengue immunisation programme in the Philippines after it was requested the company …

amgen_hq

Amgen’s patent win upheld against Sanofi-Regeneron

January 4, 2017
Medical Communications, Research and Development Amgen, Regeneron, Sanofi, patent

In March 2016, Amgen won two major patent cases against Sanofi and Regeneron over their drug, Praleunt, after it was …

syringe

Sanofi and MSD end their joint vaccines partnership

January 3, 2017
Research and Development MSD, Sanofi, Sanofi pasteur msd

With a new year comes a fresh start, and so it was the case with Sanofi and MSD’s joint vaccine …

Sanofi files lawsuit against Novo Nordisk over ‘false allegations’

January 3, 2017
Manufacturing and Production, Sales and Marketing Novo Nordisk, Sanofi

Sanofi has sued Novo Nordisk over claims made in an advertising campaign for its drug Tresiba. Sanofi has filed the …

handshake

Sanofi and Boehringer confirm successful exchange of businesses

January 3, 2017
Manufacturing and Production, Sales and Marketing Boehringer Ingelheim, Sanofi

Sanofi and Boehringer Ingelheim have confirmed the successful completion of the exchange of Sanofi’s animal health business (Merial, based in …

jj_2johnson_and_johnson

Actelion acquisition hokey-cokey continues with J&J returning to table

December 22, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actelion, Johnson & Johnson, Sanofi

The Actelion takeover saga continues with Johnson & Johnson back in the game, and now re-entering into exclusive negotiations. Actelion …

The Gateway to Local Adoption Series

Latest content